Sign in
CompletedNo phase

SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence

Key facts

Who runs it
Karen Derefinko, PhD
Where
Memphis, United StatesSee the site
Trial code
Status
Completed
People taking part
332 people enrolled
Started
1 Feb 2022
Ended
1 Feb 2025
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Contingency Management
  • Brief Motivational Interviewing + Substance Free Activities + Mindfulness
Record updated
25 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Present with symptoms of Opioid Use Disorder
  • Eligible of receipt of buprenorphine-naloxone medication as determined by Study Doctor
  • Access to a telephone

Who cannot take part

  • Under 18 years old
  • Unable to understand spoken English

Where in United States

  • University of Tennessee Health Science CenterMemphis, United States

About the trial

What the trial wants to find out

The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM).

The 3 groups in the trial

  • Contingency Management (CM)Existing treatment, for comparison

    CM is a behavioral method that employs external rewards for target behavior. Participants will receive gift cards for adhering to treatment (attending physician visits and being adherent to buprenorphine-naloxone) for their first 4 clinic visits.

    Treatment: Contingency Management

  • Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM)Existing treatment, for comparison

    Participants will receive the BSM intervention at 4 timepoints.

    Treatment: Brief Motivational Interviewing + Substance Free Activities + Mindfulness

  • BSM+CMExisting treatment, for comparison

    BSM+CM is a combination of the two other arms. Participants may be randomized to this arm only in stage 2 of the SMART design.

    Treatment: Contingency Management and Brief Motivational Interviewing + Substance Free Activities + Mindfulness

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Testing the Effects of Contingency Management and Behavioral Economics on Buprenorphine-Naloxone Treatment Adherence Using a Sequential Multiple Assignment Randomized Trial (SMART) Design
Publications
Record updated
25 February 2025